Akhtar Ashfaq, M.D., FACP, FASN

Dr. Akhtar Ashfaq is a member of the American Kidney Fund Board of Trustees and serves on the Medical Advisory, Public Support and Kidney Disease Prevention, Education & Outreach Committees.

Dr. Ashfaq is an internist and nephrologist by training and is board-certified in both internal medicine and nephrology. After finishing medical school, Dr. Ashfaq did his internal medicine internship and residency at Good Samaritan Hospital, University Of Cincinnati in Cincinnati, Ohio where he was also a chief resident. He then joined North Shore University Hospital, Cornell University School of Medicine for a fellowship in nephrology, and then joined a private practice in Lewistown, Pennsylvania for a short time. In 1997, Dr. Ashfaq was appointed to the faculty of North Shore University Hospital and then to the faculty of North Shore-LIJ Health System, Albert Einstein College of Medicine.

During this time he served as associate program director of the nephrology fellowship program, director of inpatient services and director of clinical trials. In 2005, Dr. Ashfaq was appointed as associate chief of the division of nephrology and he stayed in this position until April 2009 when he left academia and joined Amgen as clinical research medical director where he led the North American medical team for Epogen® and was medical lead for policy, strategy and advocacy for Amgen’s nephrology franchise. He also represented Amgen on Kidney care partners, a coalition of several stakeholders serving the nephrology community.

During his career, Dr. Ashfaq has published in major nephrology journals, has contributed to internal medicine and nephrology text books, and has received many teaching awards. He has been a reviewer for most of the journals and also served as a reviewer of NephSAP and has been on the editorial board of Journal of Nephrology. He founded the Long Island (New York) chapter of the Polycystic Kidney Disease Foundation.

Dr. Ashfaq’s major area of interest is patient awareness and education and improving the lives of patients with chronic kidney disease.